Article: NOVUSPHARMA SPA ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED 30 SEPTEMBER 2001.

PR Newswire, London, November 13. This press release is transmitted on behalf of Novuspharma SpA.

Co-founders and managers form syndicate and extend lock-up agreement

Bresso, Italy -

Novuspharma SpA (Nuovo Mercato: NOV.MI), a biotechnology company focused on cancer, today announces financial results for the third quarter ended 30 September 2001 and an update on clinical development. The Company also announces that its co-founders and managers, who together own approximately 10% of Novuspharma, have formed a syndicate and extended their lock-up agreement on a staged basis until November 2004.

Highlights:

* BBR 2778 commenced ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!